Document is current

Article History

Received: 15 April 2025

Accepted: 3 July 2025

First Online: 14 July 2025

Declarations

:

: The project was approved by the ethics committee of Northwestern and Central Switzerland—EKNZ () in March 2020 (BASEC No. 2020-00584). Patients’ consent was waived following the Declaration of Helsinki and its later amendments [].

: Not applicable.

: Simon A. Amacher received grants from the Mach-Gaensslen Foundation Switzerland and the Nora van Meeuwen-Haefliger Foundation of the University of Basel, Switzerland outside the present work. Sira M. Baumann reports no disclosures. Paulina SC Kliem reports no disclosures. Dominik Vock reports no disclosures. Yasmin Erne reports no disclosures. Pascale Grzonka reports no disclosures. Sebastian Berger reports no disclosures. Sabina Hunziker is supported by the Swiss National Foundation (SNF) (Ref 10001C_192850/1 and 10531C_182422), the Gottfried Julia Bangerter-Rhyner Foundation (8472/HEG-DSV), and the Swiss Society of General Internal Medicine (SSGIM). Martin Lohri reports no disclosures. Caroline E. Gebhard reports no disclosures. Mathias Nebiker reports no disclosures. Luca Cioccari received grants from the Research Fund of the Clinical Trials Unit, University of Bern, and from the Foundation for Research in Anaesthesia and Intensive Care, University Hospital of Bern, and from the Research Council of the Cantonal Hospital of Aarau, Switzerland as well as educational grants from Hamilton Medical and Fresenius Medical Care and speaker honoraria from OrphaSwiss. All are not related to the present work. Raoul Sutter received research grants from the Swiss National Foundation (No 320030_169379), the Research Fund of the University Basel, the Scientific Society Basel, and the Gottfried Julia Bangerter-Rhyner Foundation. He received personal grants from UCB-pharma and holds stocks from Alcon, Novartis, Roche, Sandoz, and Johnson & Johnson.